By activating the AKT/mTOR signal, ANRIL upregulates GLUT1 and LDHA expression, thus increasing glucose uptake and promoting cancer progression in NPC cells [40]. This evidence concerns the gene CDKN2B-AS1 and nasopharyngeal carcinoma.